Filing Flows

Filing Flows › China Pharma Holdings (CPHI) › Recalls, complaints & regulation

China Pharma Holdings (CPHI): recalls

China Pharma Holdings (CPHI) beyond its filings: 1 recall in the last 12 months (1 in five years, 0 Class I).

Latest recalls

China Pharma Holdings' latest quarter

China Pharma Holdings, Q2 2026: revenue $948K (-8% year over year), operating margin -151.0%, net loss $1.5M, operating cash flow −$33K. The chart follows the revenue to costs, profit and cash.

Questions

Has China Pharma Holdings had any recalls?

1 recall on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.